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IWeP86ltn vitro activities of SCH 27899 (ziracin. ZIR).
quinupristin/dalfopristin (synercld. SYN). linezolid (UN),
vancornydn (VAN) and other older agents against 255 dinical
isolates of oxadllin resistant Staphylococcus aureus isolated
over four years
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At 16 mg/l (4 mg/l) the susceptibiliry of the E. coli strains was restored by
piperacillin-tazobactam in 82% (59%) vs. piperacillin-sulbactam in 55%
(34%). Corresponding to this piperaciIlin-tazobaetam yielded MIC90-
values which were 2 dilutions lower than those of piperacillin-sulbactam.
conclusion: Especially for strains producing enzymes ofthe TEM-types the
MICs of penicillins can be reduced by combinations of penicillins plus f3-
lactamase inhibitors. The results of this study confirm that the susceptibiliry
of E. coli-strains against piperacillin is partly restorable by tazobactam and
sulbaetam.
The reconstitutional effect oftazobactam in vitro was much stronger than
that ofsulbactam. The clinical relevance has stilI to be evaluated.
Objectives: To evaluate the activity ofpiperacillin-tazobactam in compar-
ison to piperacillin-sulbaetam against E. coli strains with resistance or
intermediate susceptibiliry against piperacillin.
Methods: A total of 216 non copy strains from patients with different
infectious diagnoses were collected during the period August 1998-August
1999.
The MICs were determined by the microdilution test according to DIN
(German Institution for Standardization) guidelines. The testing was per-
formed in Mueller Hinton broth and an inoculum size of5 x loS cfu/ml. The
microdilution trays were incubated at 36°C for 20 h.
Results: Table: Activity ofpiperacillin-tazobactam and piperacillin-sulbac-
tam against E. coli (n = 216). Cumulative counts at each MIC (mg/I)
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Objectives: To calibrate the disk diffusion method for fluidic acid and
staphylococci by using single-strain regression analysis (SRA) as a tool for
choosing disk content and establishing interpretive zone breakpoints.
Methods: Routine disk diffusion tests of fluidic acid against staphylococci
are performed according to SRGA with a 50 ug disk in Sweden (breakpoints
available) and according to NCClS with a 10 ug disk in Estoni2 (no
breakpoints available). SRA equation constants were calculated using five
different fusidic acid disk contents (1.5, 5, IS, SO, ISO ug), and these disks
were tested on five separate occasions against quality control strain S. aureus
ATCC 29213 in both countries using their own routine method. Equation
constants were used for calculating zone breakpoints corresponding to
recommended (SRGA) MIC breakpoints (S < = 0.5 mgfL, R > = 1
mgfL)·
Results: Histograms based on routine tests from Karolinska Hospital,
Stockholm and Institute of Microbiology, Tartu, showed clustering of
wild type strains around 41 mm and 30 mm, respectively, reflecting both
different disk contents and different inocula. This was verified by the
calculated SRA constant A, which was quite different in the two labora-
tories, indicating methodological variations. Zone breakpoints calculated
from the equations were validated by comparison with the respective
routine histograms. Breakpoints for the suggested lower disk content 10
ug in Sweden were validated by further routine testing and histogram
analysis.
Conduslons: SRA calibration served as a useful tool to establish test
conditions and interpretive criteria for susceptibility testing of fusidic acid
against staphylococci.
Objectives: Fusidic acid is a potentially important antibiotic for the treat-
ment of C. difliciIe colitis. There are, however, no interpretive zone break-
points issued by reference authorities for this combination. We applied single
strain regression analysis, SRA, to set breakpoints for the individual
laboratory according to recommended MIC-limits for susceptibility.
Methods: Forty strains ofC. difliciIe from colitis cases and reference strain
ATCC 9689 were included and their fusidic acid MIC values determined
using the E-test. Culture of the strains on Columbia blood agar base
supplemented with 5% horse blood was performed in an anaerobic cabinet.
Disk tests followed standardized methodology ofSRGA with modifications
for anaerobic growth. Fusidic acid disks for SRA contained 1.5,5, 15,50 and
150 /-Ig per disk. MIC-limits recommended by SRGA for fusidic acid are S
< = 0.5 J.lg/ml and R = > 1 J.lg/ml.
Results: MIC results indicated possible interpretive errors of rype I. The
absence ofan I category according to SRGA increased error rates. NCClS
fusidic acid MIC limit S < 2.0 mg/l would be more appropriate. SRA
calculations for 40 strains gave a mean curve used to translate MIC limits to
inhibition zones. Using NCClS limits the interpretive zone breakpoints
were S = > 30 mm, R < = 29 mm. No interpretive crrors occurred in disk
test interpretations.
Conclusions: SRA calculations can be used in the individual laboratory to
determine interpretive zone breakpoints for disk testing according to
reference MIC limits.
IWeP90!tn vitro activity of daptomycin against contemporary
Gram-positive dinical isolates from 11 North American Medical
Centers (NAMe)
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IIlockground: Isolation of ORSA with reduced susceptibility to VAN has
been reported worldwide in at least six patients. Several new drugs with
novel mechanisms of activity against ORSA and other Gram-positive
organisms are being developed.
Objectives: To determine if ORSA susceptibility to VAN is decreasing at
our institution and to measure the in vitro activities of new antimicrobial
agents against ORSA.
Method: 255 strains of ORSA cultured from blood, respiratory tract and
wound cultures ofindividual patients at our institution during the last 4 years
were tested by the agar dilution method with an inoculum of 104 cfu/spot
and 24 h incubation at 35° C. ZIR was tested using the Etest. Geometric
mean (GM) MICs were calculated for VAN for strains isolated during each
of the 4 years.
Results: The VAN GM MICs ~g/ml)were as follows: 0.85 in 1996, 0.73 in
1997,0.68 in 1998, and 0.91 in 1999. The MICSO/90 for the other agents were
ZIR 0.75/1, SYN 0.5/0.5, LIN 1./2, rifampin 0.03/2, doxycycline 0.125/1,
TMP/SMX ~ 0.5/9.5/ > 4/76, and trovafloxacin 1.0/4. Most strains were
resistant to clindamycin, gentamicin, and ciprofloxacin.
Conclusions: There was no significant change in VAN MICs during the past
4 years and no homo-resistant strains with VAN MIC > 2 J.lg/ml were
detected, in spite of heavy usage at our institution. ZIR, SYN, and lIN
showed excellent activiry with no resistant strains encountered.
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Objectives: Daptomycin (DAP) is a lipopeptide which. in the presence of
free caldum (Ca + +), is active against Gram-positive bacteria. IJAl' and
vancomycin (VANC) were tested against 2803 clinical isolates gathered
fromNAMC.
Methods: For broth microdilution tests, Mueller-Hinton broth contained
NCClS recommended Ca + + at 25 mg/l and DAP was tested in a second
broth adjusted to SO mg/l Ca + +.
